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Background: Malaria continues to be a global health challenge, affecting more than half the world’s population and
causing approximately 660,000 deaths annually. The majority of malaria cases are caused by Plasmodium
falciparum and occur in sub-Saharan Africa. One of the major complications asscociated with malaria is severe
anaemia, caused by a cycle of haemoglobin digestion by the parasite. Anaemia due to falciparum malaria in children
has multifactorial pathogenesis, which includes suppression of bone marrow activity. Recent studies have shown that
haemozoin, which is a by-product of parasite haemoglobin digestion, may play an important role in suppression of
haemoglobin production, leading to anaemia. In this study we correlated the levels of erythropoietin (EPO), as an
indicator of stimulation of haemoglobin production, to the levels of monocyte acquired haemozoin in children
with both severe and uncomplicated malaria. There was a significantly negative correlation between levels of
haemozoin-containing monocytes and EPO, which may suggest that haemozoin suppresses erythropoiesis in
severe malaria. A multiple linear regression analysis and simple bar was used to investigate associations between
various haematological parameters.
Methods: To examine the levels of erythropoietin in the age categories, the levels of erythropoietin was measured
using a commercial Enyme-Linked Immunosorbent Assay (ELISA). Giemsa-stained blood smears were used to determine
percentage pigment containing monocytes. The haemozoin containing monocytes was expressed as a percentage of
the total number of monocytes. To obtain the number of haemozoin containing monocytes/μL the percentage of
haemozoin containing monocytes was multiplied by the absolute number of monocytes/μL from the automated
haematology analyzer.
Results: The levels of erythropoietin in younger children (<3 years) was significantly higher than in older children with a
similar degree of malaria anaemia (Hb levels) (p < 0.005). Haemozoin-containing monocytes were relatively higher in
severe malaria anaemia patients compared to those with uncomplicated malaria (p < 0.001).
Conclusions: Age purportedly has a direct effect on background levels of erythropoietin. With corresponding
decreased levels of erythropoietin in older children with the same degree of severe malarial anaemia, conceivably, the
bone marrows of younger children with acute malaria may be less sensitive to erythropoietin.* Correspondence: jmsabugri@gmail.com
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Malaria is an infectious disease and a major public health
problem. Malaria can be uncomplicated or severe, often
manifesting as severe anaemia, impaired consciousness or
respiratory distress [1]. Metabolic complications in severe
malaria in children include hypoglycaemia and metabolic
acidosis. Major clinical complications of severe malaria
in non-immune adults include cerebral malaria, acute
renal failure, pulmonary oedema and acute respiratory
distress syndrome.
Malaria contributes significantly to the development of
anaemia in sub-Saharan Africa and elsewhere, where the
disease is prevalent [2]. Indeed severe malarial anaemia
(SMA), defined as as anaemia with haemoglobin (Hb)
concentration of <5 g/dL with P. falciparum asexual parasit-
emia, in the absence of any other or additional identifiable
cause of anaemia [3], is the most widespread complication
of Plasmodium falciparum infection, especially among
children (WHO, 2000). The anaemia of malaria has
profound pathological effects on patients and its root
cause is multifactorial and encompasses haemolysis,
erythrophagocytosis, dyserythropoiesis, and ineffective
erythropoiesis [4-6]. Its manifestations are also complex
and defy accurate delineation. Blood transfusion as a treat-
ment for malaria has very high risks because of the high
incidence of HIV and other blood-borne infections.
In addition to direct destruction of infected erythrocytes
by the malaria parasites during schizogony and the prema-
ture removal of non-parasitized erythrocytes, reversible
suppression of erythropoiesis has also been reported to
play a key role in its pathogenesis [7]. Suppression of
erythropoiesis means a failure of the bone marrow to
respond adequately to the excessive removal of the
erythrocytes by producing more erythrocytes and to al-
leviate the anaemia. The suppression of bone marrow
function in severe anaemia patients with microscopically un-
detectable parasitaemia has been presumptively attributed
to subpatent malaria parasites [8]. However, subpatent para-
sitaemia cannot account fully for the suppression of bone
marrow function. Haemozoin and inflammatory mediators
have also been implicated in the suppression of bone mar-
row function [9,10]. Their roles and the interplay between
the various factors in the development of severe malaria an-
aemia have not been explicitly elucidated. The thrust of this
study was therefore to investigate the level of erythropoietin
and haemozoin in both severe malaria anaemia and uncom-
plicated malaria in Ghanaian children. To achieve this, levels
of erythropoietin and haemozoin containing monocytes
were measured using approved protocols.
Methods
Study subjects
This study was hospital-based,, involving children aged
1–13 years, admitted to the emergency unit of theDepartment of Child Health (DCH) of the Korle-Bu
Teaching Hospital and outpatients at the Korle-Bu
Polyclinic, both in Accra, Ghana during the peak malaria
transmission season (July to August, 2005). The patients
were examined clinically by a physician and laboratory
investigations including haematology, microscopy and
clinical chemistry carried out.
Parents/guardians of patients gave informed consent
prior to recruitment. Demographical, clinical history and
management/outcomes were also documented. This study
formed part of a larger one, which was approved by the
Institutional Review Board (IRB) and the Scientific and
Technical Committee (STC) of the Noguchi Memorial
Institute for Medical Research (NMIMR), College of
Health Sciences, University of Ghana, Legon. The study also
received the approval of the Scientific and Ethical Review
Committee of the University of Ghana Medical School,
College of Health Sciences, and University of Ghana.
Inclusion criteria for malaria patients
Inclusion criteria for malaria patients were fever (≥37.5°C)
measured within 24 hours of admission, malaria parasit-
aemia, and at least one other sign of malaria (vomiting,
diarrhoea, malaise etc.). Children with other clinical presen-
tations other than malaria or that had a positive sickling
test were excluded from the study. Patients were cate-
gorized as uncomplicated and severe malaria based on
previously established clinical characterization, haem-
atological and other indices [3,11].
Severe malaria cases had haemoglobin (Hb) ≤5g/dL and
any level of peripheral blood Plasmodium falciparum
parasitaemia, were fully conscious without severe bleeding
or convulsions and had no other cause of anaemia. SMA
also included patients who were unconscious with a
Blantyre coma score of ≤3, duration of coma >60 minutes,
any Hb value, any parasitaemia and no other neurological
diseases [3]. Uncomplicated malaria cases were patients
who were fully conscious, had malaria parasitaemia and
no severe complication as described above. The physician
examined the patients clinically and other causes of an-
aemia such as helminth infection, nutritional deficiency
and HIV infection were precluded.
Blood collection for laboratory analyses
Venous blood was collected into sterile vacutainer tubes
containing heparin and EDTA for routine diagnostic
purposes. Plasma was obtained by centrifugation using
the poor-platelet plasma (PPP) method. In this method,
the vacutainer tube containing blood samples was cen-
trifuged at 65 × g for 15 minutes at room temperature.
The supernatant which is the Rich-Platelet-Protein
(RPP) fraction was taken without disturbing the buffy
coat and put into another tube. This was again centri-
fuged at 960 × g for 10 minutes. The supernatant which is
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Celsius.
Thick and thin blood films obtained at enrollment
prior to therapy were stained with Giemsa for detection,
identification and enumeration of Plasmodium. Peripheral
parasite density was determined from thick films based on
the number of asexual forms against 300 white blood
cells (WBCs) and the value multiplied by each individual’s
WBC count from the automatic haematology analyzer
(SYSMEX, Japan) to obtain parasites per μL of blood. Ab-
solute parasite counts were calculated for each child using
either thin films (counting parasitized RBCs per 500 RBCs),
or from thick films (counting parasitized RBCs per 300
WBCs).The Quantikine IVD Epo ELISA kit was used
to determine erythropoietin levels following the manu-
facturer’s instructions.
Statistical analyses
Statistical analyses were carried out using Sigmaplot 12
(www.sigmaplot.com) and graphpad prism 5. Spearman’s
rank coefficients were calculated to assess correlations
between various parameters and levels of haemoglobin as
well as levels of haemozoin containing monocytes and
neutrophils.
Results
Clinical characteristics of study participants
A total of 100 severe and uncomplicated cases of malaria
as well as 20 age-matched healthy uninfected individ-
uals, both male and female were involved in this study.
They included 36 children with severe malaria and 64
children with uncomplicated malaria. The mean Hb for
children with complicated malaria was 3.9 g/dl and the
complicated malaria cases overall had a higher mean
parasitaemia compared to the uncomplicated malaria
cases and the 20 healthy matched controls as shown in
(Table 1). Generally, parasitaemia was high in both com-
plicated and uncomplicated malaria cases. However, the
difference between the levels of parasitaemia in both
groups was not statistically significant (P = 0.722). Rela-
tively, children with complicated malaria were younger
than children presenting with uncomplicated malaria
(Table 1). The difference in age between the two groups
was statistically significant (P <0.001).Table 1 Clinical characteristics and laboratory parameters o
uncomplicated malaria
Group N Mean age (Years) M
Complicated malaria 36 4 (1–10)* 3
Uncomplicated malaria 64 6 (1–13)* 9
Controls 20 6 (2–8)* 1
*Data are means (minimum and maximum values). N = sample size.Erythropoietin and other haematogical correlates
To investigate the association among levels of erythropoi-
etin, haemoglobin levels and age, venous blood samples
were obtained from study participants and assayed for levels
of eryrythropoietin. P. falciparum parasitaemia and haemo-
zoin load in monocytes. There was an inverse correlation
between age and Haemoglobin levels but this was not statis-
tically significant. A scattergram revealed a similar trend
using a scatterplot with multiple linear regressions with
age and haemoglobin as independent variables (Figure 1).
To investigate the age-related pattern of Erythropoietin
production in paediatric malaria, graphpad prism 5 was
used to draw a categorised bar chart of age for compli-
cated and umcomplicated malaria with erythropoietin
and haemoglobin as dependent variables. An upaired stu-
dent t test revealed a significant difference in the mean
production of erythropoietin in the different age groups
(P = 0.005) with children aged < 3 years producing more
erythropoietin compared to children aged greater than
or equal to 3 years with relatively comparable levels of
haemoglobin (Figure 2).
Role of monocyte acquired haemozoin
To investigate the possible relationship between levels of
haemozoin containing monocytes and severity of malaria
cases, a boxplot was generated for levels of haemozoin
containing monocytes in severe and uncomplicated mal-
aria (Figure 3) This revealed a significant difference in per-
centage haemozoin containing monocytes in severe and
uncomplicated malaria (P < 0.0001) with relatively higher
levels of haemozoin containing monocytes in severe mal-
aria anaemia (Figure 3). Also Hz +monocytes was nega-
tively correlated with Hb levels (p < 0.0001) (Figure 4).
Discussion
The study confirms the finding that younger children
produce higher levels of erythropoietin compared to older
children with a similar degree of anaemia (Hb levels) [12].
This finding is significant because it could partly explain
the finding that severe malarial anaemia is more common
in younger children whose bone marrow needs to be stim-
ulated by high levels of EPO to replenish the loss of eryth-
rocytes by producing new erythrocytes rapidly. Age and
haemoglobin levels are reportedly independent variablesf Ghanaian children with complicated and
ean haemoglobin (g/dL) Mean parasitaemia (parasites/uL)
.9 (2.1-4.8)* 175,026.4 (2,832-1,958,270)*
.8 (8.1-12.7)* 121,692.4 (3,618-516,870.)*
1.335 (9.6-12.5)* 302.6 (0.0-2,472)*
Figure 1 The relationship between plasma erythropoietin (log transformed), haemoglobin levels and age in paediatric malaria cases.
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erythropoietin response declines during development
at a similar degree of anaemia. Age purportedly, has a
direct effect on the background level of production of
erythropoietin. With the corresponding decreased levels
of erythropoietin in older children with the same degree
of severe malarial anaemia, conceivably, the bone mar-
rows of the younger children with acute malaria may
be less sensitive to erythropoietin. Confirmation of thisHB
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Figure 2 The plasma levels of erythropoietin (log transformed)
and haemoglobin levels in paediatric malaria cases for the
study cohort categorised by age.theory will require longitudinal studies including exam-
ination of bone biopsies from children with SMA, which
is beyond the scope of the present preliminary, cross-
sectional study.
Previous studies have established the ability of erythro-
poietin to cross the blood/brain barrier and to provide
protection against experimental injury as well as act as a
tissue protective cytokine [13,14]. It is thus plausible to
suggest that the high levels of erythropoietin in younger
children with anaemia as compared to older children with
relatively the same degree of anaemia may, presumably,
protect them against tissue damage. It may also contribute
to the low frequency of cerebral malaria in relatively youn-
ger children [13].Se
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Figure 3 Percentage of haemozoin containing monocytes in
blood films of paediatric malaria patients.
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Figure 4 Haemoglobin versus haemozoin containing monocytes.
In order to determine if haemozoin levels had any significant effect on
haemoglobin levels, Pearsson correlation coefficient was determined.
There was significant negative correlation between haemoglobin levels
and percent monocytes (P < 0.0001) with r = −0.46.
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monocytes were significantly elevated in severe malaria
anaemia compared to uncomplicated malaria. This finding
corroborates earlier findings which implicated haemo-
zoin in malaria pathogenesis through the suppression of
erythropoiesis directly or in synergy with proinflammatory
cytokines [9]. The elevated levels of haemozoin in severe
malaria anaemia could therefore be accounted for by the
increased pathogenesis therein. Besides the acquisition
of haemozoin by human monocytes purportedly plays
a crucial role in triggering severe malaria [10]. This study
also showed a significant positive correlation between levels
of erythropoietin and haemozoin containing monocytes.
This corroborates earlier findings that demonstrated that
haemozoin directly has an effect in the induction of apop-
tosis in nascent erythroid cells in malaria anaemia [15]. The
inadequate erythropoietic response in the presence of high
levels of erythropoietin, presumably results from the release
of cytokines, chemokines and lipo-peroxides upon the ex-
posure to haemozoin and these synergistically could lead to
the concomitant inhibition of erythropoiesis [16,17]. Taken
together our findings are consistent with extant literature
and support critical key findings in malaria pathogenesis
that implicate haemozoin in the direct and indirect induc-
tion of dyserythropoiesis.
Conclusion
In conclusion this study has confirmed earlier findings
that erythropoietin production is age-related with younger
children having the ability to produce more erythropoietin
during acute malaria than older children. This study also
suggests the involvement of haemozoin a parasite product
in the inhibition of erythropoiesis as the seeming robust
production of erythropoietin did not translate into higher
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